Famotidine History

Famotidine was developed by Yamanouchi Pharmaceutical Co. It was accountant in the mid-1980s by Merck & Co. and is marketed by a collective adventure amid Merck and Johnson & Johnson. The imidazole ring of cimetidine was replaced with a 2-guanidinothiazole ring. Famotidine accepted to be nine times added almighty than ranitidine, and thirty-two times added almighty than cimetidine.
It was aboriginal marketed in 1981. Pepcid RPD orally abolition tablets were appear in 1999. Generic affairs became accessible in 2001, e.g. Fluxid (Schwarz) or Quamatel.
In the United States and Canada, a artefact alleged Pepcid Complete, which combines famotidine with an acrid in a chewable book to bound abate the affection of balance abdomen acid, is available. In the UK, this artefact was accepted as Pepcidtwo above-mentioned to its cessation in April 2015.
Famotidine suffers from poor bioavailability (50%), as it is ailing acrid in the low pH of the stomach. When used in aggregate with antacids, it promotes bounded supply of these drugs to the receptor of the parietal corpuscle wall. Therefore, advisers are developing avant-garde formulations of tablets, such as gastroretentive biologic supply systems. Such tablets are retained in the abdomen for a best aeon of time, thereby convalescent the bioavailability of drugs. Bounded supply aswell increases bioavailability at the abdomen bank receptor website and increases the ability of drugs to abate acid secretion.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s